Demo Sign up Log In

Heron Therapeutics Inc (HRTX)

Cost of Revenue

$11.57M

Quarterly · Period ending: Jun 30, 2026 · USD

HRTX Cost of Revenue

Latest reported$11.57Mperiod endingJun 30, 2026

Latest reported$11.57Mperiod endingJun 30, 2026

HRTX Quarterly Cost of Revenue ($0.00 → $11.57M)

Quarterly cost of revenue

High-resolution chart · PNG

HRTX cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2001	113,319
Mar 31, 2001	93,320
Dec 31, 2000	309,080
Sep 30, 2000	116,627
Jun 30, 2000	131,885
Mar 31, 2000	2,460,000
Dec 31, 1999	3,800,000
Sep 30, 1999	1,600,000
Jun 30, 1999	1,500,000
Mar 31, 1999	1,200,000
Dec 31, 1998	1,000,000
Sep 30, 1998	1,700,000
Jun 30, 1998	1,600,000
Mar 31, 1998	1,400,000
Dec 31, 1997	1,500,000
Sep 30, 1997	1,600,000
Jun 30, 1997	1,800,000
Mar 31, 1997	1,200,000
Dec 31, 1996	2,200,000
Sep 30, 1996	1,800,000
Jul 25, 1996	2,600,000
Mar 31, 1996	2,900,000
Dec 31, 1995	2,400,000
Sep 30, 1995	1,600,000
Jun 30, 1995	3,000,000
Mar 31, 1995	2,700,000
Dec 31, 1994	600,000
Sep 30, 1994	2,500,000
Jun 30, 1994	2,800,000
Mar 31, 1994	3,200,000
Dec 31, 1993	2,500,000
Sep 30, 1993	2,300,000
Jun 30, 1993	3,200,000
Mar 31, 1993	1,300,000
Dec 31, 1992	1,900,000
Sep 30, 1992	800,000
Jun 30, 1992	700,000
Mar 31, 1992	500,000
Dec 31, 1991	300,000
Sep 30, 1991	300,000
Jun 30, 1991	300,000
Mar 31, 1991	200,000
Dec 31, 1990	400,000
Sep 30, 1990	200,000
Jun 30, 1990	300,000
Mar 31, 1990	300,000
Dec 31, 1989	300,000
Sep 30, 1989	100,000
Jun 30, 1989	100,000
Mar 31, 1989	0
Dec 31, 1988	0
Sep 30, 1988	0
Jun 30, 1988	0
Mar 31, 1988	0
Dec 31, 1987	0
Sep 30, 1987	0
Jun 30, 1987	0
Mar 31, 1987	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.